S. Barbarot

16.7k citations

251 papers · 6.3k indexed · 5 hit papers · h-index 40

Impact in

Immunology and Allergy top 0.1%
- Allergic Rhinitis and Sensitization
- Food Allergy and Anaphylaxis Research
Dermatology top 0.05%
- Dermatology and Skin Diseases
- Contact Dermatitis and Allergies

Papers in

Dermatology 118
- Dermatology and Skin Diseases 88
Immunology and Allergy 67
- Allergic Rhinitis and Sensitization 53
- Food Allergy and Anaphylaxis Research 33

Co-authors: Marjolein de Bruin‐Weller Giampiero Girolomoni Laurent Eckert S. Auziere J. Mazereeuw‐Hautier J.‐F. Stalder L. Puig Alain Taı̈eb
Journals: British Journal of Dermatology (22 papers)Journal of the European Academy of Dermatology and Venereology (14 papers)Journal of the American Academy of Dermatology (13 papers)Pediatric Dermatology (11 papers)Acta Dermato Venereologica (7 papers)
Partner nations: France United States Germany

In The Last Decade

S. Barbarot

219 papers receiving 6.1k citations

Hit Papers

5 papers align trajectories log scale

Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis 2021 · 305 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 JAMA Dermatology
2021 Annals of Allergy Asthma & Immunology
2018 Allergy
2018 Journal of the European Academy of Dermatology and Venereology
2016 Journal of the European Academy of Dermatology and Venereology

Peers

Countries citing papers authored by S. Barbarot

Since Specialization

Citations

This map shows the geographic impact of S. Barbarot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Barbarot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Barbarot more than expected).

Fields of papers citing papers by S. Barbarot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Barbarot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Barbarot. The network helps show where S. Barbarot may publish in the future.

Co-authorship network

The 25 scholars most cited alongside S. Barbarot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Barbarot Line = papers co-authored together S. Barbarot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A postzygotic GNA13 variant upregulates the RHOA/ROCK pathway and alters melanocyte function in a mosaic skin hypopigmentation syndrome Nature Communications ·Nick Hatcher, Qiu Jun-qin, Paul Kuentz, Rachida Tacine, Marie Vincent, S. Barbarot, Fanny Morice‐Picard, F. Boralévi, Vladimir Neuymin, J. Mazereeuw‐Hautier, Yannis Duffourd, Laurence Faivre, Arthur Sorlin, P. Vabres, Jérôme Delon	2025	2
2	Questions a patient with moderate to severe atopic dermatitis would like to be asked: Data from a qualitative study conducted by anthropologists SHILAP Revista de lepidopterología ·Симонова Марина Олеговна, Stéphane Héas, Сергій СИЧ, 清彦沼上, L. Misery, S. Barbarot, Amartya Roy	2024	0
3	Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate‐to‐severe atopic dermatitis SHILAP Revista de lepidopterología ·D. Staumont‐Sallé, S. Barbarot, Jean‐David Bouaziz, 将臣山﨑, Claire Clibborn, A. Du‐Thanh, Claire Feeney, T. Boscal de Reals, L. Misery, Audrey Nosbaum, Julien Sénéschal, A. Soria, Fan Zhang	2023	0
4	Factors associated with early relapse of infantile haemangioma in children treated for at least six months with oral propranolol: A case-control study using the 2014–2021 French Ouest DataHub Annales de Dermatologie et de Vénéréologie ·朱亚涛, A. Maruani, S. Barbarot, C. Abasq, Ludovic Martin, Joseph Herbert, Thomas Goronflot, Gary W. Husa, André Happe, Alexis Descatha, Jean‐Marie Chrétien, Alain Beuchée, H. Adamski, A. Dupuy, Guillaume Bouzillé, Emmanuel Oger, C. Droitcourt	2023	3
5	Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials American Journal of Clinical Dermatology ·Eric L. Simpson, Andrew Pink, Andrew Blauvelt, Melinda Gooderham, April W. Armstrong, Margitta Worm, Norito Katoh, Ketty Peris, L. Puig, S. Barbarot, Vera Dobelmann, Louise Abildgaard Steffensen, ZULMARA LUIZA GESSER, Andreas Wollenberg	2023	15
6	French cohort of children and adolescents with neurofibromatosis type 1 and symptomatic inoperable plexiform neurofibromas: CASSIOPEA study European Journal of Medical Genetics ·P. Wolkenstein, Yves Chaix, Kohesi dan Koherensi, Mona Amini‐Adlé, S. Barbarot, Maricruz Lacalle-Calderón, E.V.T. Engmann, 邵红能, Isabelle Aerts	2023	1
7	Phototherapy for atopic dermatitis: A survey of European practice Journal of the European Academy of Dermatology and Venereology ·昌弘林, Louise A. A. Gerbens, Phyllis I. Spuls, Soudeh Mashayekhi, Mette Deleuran, S. Barbarot, Andreas Wollenberg, J. Ferguson, Sally H. Ibbotson, Carsten Flohr	2023	1
8	Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis American Journal of Clinical Dermatology ·Jonathan I. Silverberg, David N. Adam, L. Všetičková, Sunil Kalia, Jan Gutermuth, Andreas Pinter, Andrew Pink, Andrea Chiricozzi, S. Barbarot, Vera Dobelmann, J. E. C., Stephan Weidinger	2022	37
9	The Family Impact of Atopic Dermatitis in the Pediatric Population: Results from an International Cross-sectional Study The Journal of Pediatrics ·S. Barbarot, Thomas P. Mackey, Abhijit Gadkari, Eric L. Simpson, Stephan Weidinger, Paola Mina‐Osorio, Ana B. Rossi, Lysel Brignoli, Nuri Saad Mohamed Algheriani, Isabelle Guillemin, Miriam C. Fenton, Gavrishko S.G., Puneet Mahajan, Dimittri Delevry, Ashish Bansal, Laurent Eckert	2022	30
10	Social Media Platforms Listening Study on Atopic Dermatitis: Quantitative and Qualitative Findings Journal of Medical Internet Research ·RA Gab El-Rab, G. Gryshchuk, Andrea Toto, P. Barigelli-Calcari, Samartha Khare, S. Barbarot, L. Misery, Stéphane Héas, Adel Mebarki, Nathalie Texier, Stéphane Schück	2021	11
11	Factors influencing quality of life in children with low‐flow vascular malformations: a qualitative study using focus groups Journal of the European Academy of Dermatology and Venereology ·MICHAEL KALVIUS, Daniel Sane, A. Maruani, Christine Labrèze, S. Barbarot, H. Aubert, Christian Ghiugan, Jason Shourick, Priscilla Lissett Vega Guerrero, I. Dreyfus, J. Mazereeuw‐Hautier	2020	2
12	Drug survival and postdrug survival of systemic treatments in a national French cohort of children with atopic dermatitis British Journal of Dermatology ·William Mundon, S. Barbarot, Кондакова Елизавета Сергеевна, F. Poizeau, E. Mahé, E. Puzenat, J. Delaunay, S. Mallet, D. Bessis, A. Maruani, J. Miquel, Nadia Raison‐Peyron, C. Abasq, Alexandria T. Phan, A. Du‐Thanh, I. Kupfer, B. Bonniaud, Guillaume Bouzillé, A. Dupuy, C. Droitcourt, (unknown)	2020	0
13	Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials Journal of Dermatological Treatment ·S. Barbarot, Andreas Wollenberg, Jonathan I. Silverberg, Mette Deleuran, Giovanni Pellacani, J.C. Armario-Hita, Ahmad Shamsuddin Ahmad, Brad Shumel, Laurent Eckert, A. Gadkari, Yuan Lü, Ana B. Rossi	2020	14
14	Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials British Journal of Dermatology ·Jonathan I. Silverberg, Eric L. Simpson, Marius Ardeleanu, Diamant Thaçi, S. Barbarot, Jerry Bagel, Z. Chen, Laurent Eckert, J. Chao, Andrew Korotzer, E. Rizova, Ana B. Rossi, Yuan Lü, E. Granz, Thomas Hultsch, Gianluca Pirozzi, Bolanle Akinlade	2019	44
15	TRE atment of AT opic eczema ( TREAT ) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries British Journal of Dermatology ·Hamid Lmou, Louise A. A. Gerbens, Angela L. Bosma, Christian Apfelbacher, Alan D. Irvine, B.W.M. Arents, S. Barbarot, Mette Deleuran, Lawrence F. Eichenfield, Andrea Manca, Jochen Schmitt, Christian Vestergaard, Dmitri Wall, Stephan Weidinger, M S Anjali, Phyllis I. Spuls, Carsten Flohr, (unknown)	2019	21
16	New splicing pathogenic variant in EBP causing extreme familial variability of Conradi–Hünermann–Happle Syndrome European Journal of Human Genetics ·Mathilde Pacault, Marie Vincent, Thomas Besnard, Caroline Kannengiesser, Claire Bénéteau, S. Barbarot, Xénia Latypova, 정긍식, Antonin Lamazière, Norbert Winer, Madeleine Joubert, Stéphane Bezieau, Bertrand Isidor, Sandra Mercier, Mathilde Nizon, Stéphanie Leclerc‐Mercier, S. Hadj‐Rabia, Fabienne Dufernez	2018	5
17	Dysfonctionnement exécutif chez les enfants d’âge préscolaire atteints d’une neurofibromatose de type 1 Revue de neuropsychologie ·Sivathasan, S. Barbarot, Hortensia Reyes, Arnaud Roy	2018	1
18	Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1 Human Molecular Genetics ·Audrey Sabbagh, Éric Pasmant, Ingrid Laurendeau, Béatrice Parfait, S. Barbarot, B. Guillot, P. Combemale, S. Ferkal, Michel Vidaud, Patrick Aubourg, Dominique Vidaud, P. Wolkenstein	2009	97
19	Patient-Oriented SCORAD: A Self-Assessment Score in Atopic Dermatitis Dermatology ·Fiona Morrow, S. Barbarot, Alain Taı̈eb, Thomas L. Diepgen, Tatyana P. Sokolova, 日本貨物航空株式会社, V. Sibaud, J.F. Stalder	2009	50
20	Modalités de découverte des cancers chez les enfants atteints de neurofibromatose de type 1 Archives de Pédiatrie ·S. Barbarot, Nadège Corradini, Christine Thomas, Alexandre Boutet, J.F. Stalder, A. Dávid, V. O. Sorokina	2008	0

About S. Barbarot

S. Barbarot is a scholar working on Dermatology, Immunology and Allergy, Neurology, Rheumatology and Physiology, having authored 251 papers that have together received 6.3k indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (88 papers), Allergic Rhinitis and Sensitization (53 papers), Asthma and respiratory diseases (39 papers), Food Allergy and Anaphylaxis Research (33 papers), Neurofibromatosis and Schwannoma Cases (30 papers), Skin and Cellular Biology Research (18 papers), Genetic and rare skin diseases. (16 papers) and Vascular Malformations and Hemangiomas (16 papers). The work is most often cited by research in Immunology and Allergy (2.7k citations), Dermatology (3.8k citations), Physiology (1.4k citations), Rheumatology (805 citations) and Neurology (808 citations). S. Barbarot has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Marjolein de Bruin‐Weller, Giampiero Girolomoni, Laurent Eckert, S. Auziere, J. Mazereeuw‐Hautier, J.‐F. Stalder, L. Puig, Alain Taı̈eb, Eric L. Simpson and Mette Deleuran. Their work appears in journals such as British Journal of Dermatology, Journal of the European Academy of Dermatology and Venereology, Journal of the American Academy of Dermatology, Pediatric Dermatology and Acta Dermato Venereologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact